{"id":"https://openalex.org/W1979920873","doi":"https://doi.org/10.1016/j.tiv.2010.04.007","title":"Screening for phospholipidosis induced by central nervous drugs: Comparing the predictivity of an in vitro assay to high throughput in silico assays","display_name":"Screening for phospholipidosis induced by central nervous drugs: Comparing the predictivity of an in vitro assay to high throughput in silico assays","publication_year":2010,"publication_date":"2010-04-28","ids":{"openalex":"https://openalex.org/W1979920873","doi":"https://doi.org/10.1016/j.tiv.2010.04.007","mag":"1979920873","pmid":"https://pubmed.ncbi.nlm.nih.gov/20430096"},"language":"en","primary_location":{"id":"doi:10.1016/j.tiv.2010.04.007","doi":"https://doi.org/10.1016/j.tiv.2010.04.007","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.tiv.2010.04.007","pdf_url":null,"source":{"id":"https://openalex.org/S39580544","display_name":"Toxicology in Vitro","issn_l":"0887-2333","issn":["0887-2333","1879-3177"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Toxicology in Vitro","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5080731813","display_name":"Natalie Mesens","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Natalie Mesens","raw_affiliation_strings":["Genetic and Exploratory Toxicology, Global Preclinical Development, Johnson&Johnson Pharmaceutical Research and Development, 2340 Beerse, Belgium. nmesens@its.jnj.com","Genetic and Exploratory Toxicology, Global Preclinical Development, Johnson&Johnson Pharmaceutical Research and Development (J&JPRD), 2340 Beerse, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genetic and Exploratory Toxicology, Global Preclinical Development, Johnson&Johnson Pharmaceutical Research and Development, 2340 Beerse, Belgium. nmesens@its.jnj.com","institution_ids":["https://openalex.org/I4405282460"]},{"raw_affiliation_string":"Genetic and Exploratory Toxicology, Global Preclinical Development, Johnson&Johnson Pharmaceutical Research and Development (J&JPRD), 2340 Beerse, Belgium","institution_ids":["https://openalex.org/I4405282460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042590967","display_name":"Margino Steemans","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Margino Steemans","raw_affiliation_strings":["Genetic and Exploratory Toxicology, Global Preclinical Development, Johnson&Johnson Pharmaceutical Research and Development (J&JPRD), 2340 Beerse, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genetic and Exploratory Toxicology, Global Preclinical Development, Johnson&Johnson Pharmaceutical Research and Development (J&JPRD), 2340 Beerse, Belgium","institution_ids":["https://openalex.org/I4405282460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103570003","display_name":"Erik Hansen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Erik Hansen","raw_affiliation_strings":["Genetic and Exploratory Toxicology, Global Preclinical Development, Johnson&Johnson Pharmaceutical Research and Development (J&JPRD), 2340 Beerse, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genetic and Exploratory Toxicology, Global Preclinical Development, Johnson&Johnson Pharmaceutical Research and Development (J&JPRD), 2340 Beerse, Belgium","institution_ids":["https://openalex.org/I4405282460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051003129","display_name":"Geert R. Verheyen","orcid":"https://orcid.org/0000-0001-9268-9228","observed_orcids":["https://orcid.org/0000-0001-9268-9228"]},"institutions":[{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Geert R. Verheyen","raw_affiliation_strings":["Genetic and Exploratory Toxicology, Global Preclinical Development, Johnson&Johnson Pharmaceutical Research and Development (J&JPRD), 2340 Beerse, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genetic and Exploratory Toxicology, Global Preclinical Development, Johnson&Johnson Pharmaceutical Research and Development (J&JPRD), 2340 Beerse, Belgium","institution_ids":["https://openalex.org/I4405282460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004586239","display_name":"Freddy Van Goethem","orcid":"https://orcid.org/0009-0000-5672-0048","observed_orcids":["https://orcid.org/0009-0000-5672-0048"]},"institutions":[{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Freddy Van Goethem","raw_affiliation_strings":["Genetic and Exploratory Toxicology, Global Preclinical Development, Johnson&Johnson Pharmaceutical Research and Development (J&JPRD), 2340 Beerse, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genetic and Exploratory Toxicology, Global Preclinical Development, Johnson&Johnson Pharmaceutical Research and Development (J&JPRD), 2340 Beerse, Belgium","institution_ids":["https://openalex.org/I4405282460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5065780782","display_name":"Jaques Van Gompel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jaques Van Gompel","raw_affiliation_strings":["Genetic and Exploratory Toxicology, Global Preclinical Development, Johnson&Johnson Pharmaceutical Research and Development (J&JPRD), 2340 Beerse, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genetic and Exploratory Toxicology, Global Preclinical Development, Johnson&Johnson Pharmaceutical Research and Development (J&JPRD), 2340 Beerse, Belgium","institution_ids":["https://openalex.org/I4405282460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5080731813"],"corresponding_institution_ids":["https://openalex.org/I4405282460"],"apc_list":{"value":4200,"currency":"USD","value_usd":4200},"apc_paid":null,"fwci":3.6912,"has_fulltext":false,"cited_by_count":36,"citation_normalized_percentile":{"value":0.92667084,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"24","issue":"5","first_page":"1417","last_page":"1425"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.5034000277519226,"subfield":{"id":"https://openalex.org/subfields/1703","display_name":"Computational Theory and Mathematics"},"field":{"id":"https://openalex.org/fields/17","display_name":"Computer Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.5034000277519226,"subfield":{"id":"https://openalex.org/subfields/1703","display_name":"Computational Theory and Mathematics"},"field":{"id":"https://openalex.org/fields/17","display_name":"Computer Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12281","display_name":"Animal testing and alternatives","score":0.40700000524520874,"subfield":{"id":"https://openalex.org/subfields/3404","display_name":"Small Animals"},"field":{"id":"https://openalex.org/fields/34","display_name":"Veterinary"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14072","display_name":"Immunotoxicology and immune responses","score":0.008100000210106373,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/drug-induced-phospholipidosis","display_name":"drug-induced phospholipidosis","score":0.9599999785423279},{"id":"https://openalex.org/keywords/central-nervous-system-drugs","display_name":"central nervous system drugs","score":0.8899999856948853},{"id":"https://openalex.org/keywords/in-silico-prediction-models","display_name":"in silico prediction models","score":0.9789999723434448},{"id":"https://openalex.org/keywords/false-positive-rate","display_name":"false positive rate","score":0.796999990940094},{"id":"https://openalex.org/keywords/physicochemical-properties","display_name":"physicochemical properties","score":0.7480000257492065},{"id":"https://openalex.org/keywords/octanol-water-partition-coefficient","display_name":"octanol-water partition coefficient","score":0.5059999823570251},{"id":"https://openalex.org/keywords/akt","display_name":"Akt","score":0.7870000004768372},{"id":"https://openalex.org/keywords/plasma-concentration","display_name":"plasma concentration","score":0.6769999861717224},{"id":"https://openalex.org/keywords/drug-safety-testing","display_name":"drug safety testing","score":0.5299999713897705}],"concepts":[{"id":"https://openalex.org/C2779934242","wikidata":"https://www.wikidata.org/wiki/Q7187520","display_name":"Phospholipidosis","level":4,"score":0.9954240322113037},{"id":"https://openalex.org/C2775905019","wikidata":"https://www.wikidata.org/wiki/Q192572","display_name":"In silico","level":3,"score":0.9285743236541748},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.7849065065383911},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.6042465567588806},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.5941764712333679},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5464866757392883},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5391114354133606},{"id":"https://openalex.org/C51323132","wikidata":"https://www.wikidata.org/wiki/Q626251","display_name":"High-throughput screening","level":2,"score":0.4922241270542145},{"id":"https://openalex.org/C33618052","wikidata":"https://www.wikidata.org/wiki/Q6013136","display_name":"In vitro toxicology","level":3,"score":0.4879314601421356},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4165131747722626},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.41222095489501953},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3256815969944},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.2504468560218811},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.13647326827049255},{"id":"https://openalex.org/C2778918659","wikidata":"https://www.wikidata.org/wiki/Q186915","display_name":"Phospholipid","level":3,"score":0.12798047065734863},{"id":"https://openalex.org/C41625074","wikidata":"https://www.wikidata.org/wiki/Q176088","display_name":"Membrane","level":2,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D002460","descriptor_name":"Cell Line","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002491","descriptor_name":"Central Nervous System Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002491","descriptor_name":"Central Nervous System Agents","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":true},{"descriptor_ui":"D003198","descriptor_name":"Computer Simulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008064","descriptor_name":"Lipidoses","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D008064","descriptor_name":"Lipidoses","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D010743","descriptor_name":"Phospholipids","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D057166","descriptor_name":"High-Throughput Screening Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.tiv.2010.04.007","doi":"https://doi.org/10.1016/j.tiv.2010.04.007","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.tiv.2010.04.007","pdf_url":null,"source":{"id":"https://openalex.org/S39580544","display_name":"Toxicology in Vitro","issn_l":"0887-2333","issn":["0887-2333","1879-3177"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Toxicology in Vitro","raw_type":"journal-article"},{"id":"pmid:20430096","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20430096","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Toxicology in vitro : an international journal published in association with BIBRA","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":22,"referenced_works":["https://openalex.org/W1525426495","https://openalex.org/W1968037013","https://openalex.org/W1987433097","https://openalex.org/W1993015516","https://openalex.org/W2011523232","https://openalex.org/W2014084301","https://openalex.org/W2043545228","https://openalex.org/W2044580929","https://openalex.org/W2055236806","https://openalex.org/W2061119131","https://openalex.org/W2070163884","https://openalex.org/W2084845010","https://openalex.org/W2088827589","https://openalex.org/W2134206147","https://openalex.org/W2147123014","https://openalex.org/W2151962691","https://openalex.org/W2158646614","https://openalex.org/W2233377542","https://openalex.org/W2417072977","https://openalex.org/W2417530412","https://openalex.org/W2606740596","https://openalex.org/W4256649750"],"related_works":["https://openalex.org/W2019660907","https://openalex.org/W2765413812","https://openalex.org/W2330516038","https://openalex.org/W2580657253","https://openalex.org/W2132842487","https://openalex.org/W1986702471","https://openalex.org/W4221114051","https://openalex.org/W2108940750","https://openalex.org/W1993980891","https://openalex.org/W2147123014"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}